These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 13175938
1. [On the functional pathology and therapy of hepatobiliary disease]. KOCH D. Medizinische; 1954 Apr 03; 14():473-5. PubMed ID: 13175938 [No Abstract] [Full Text] [Related]
2. [Importance of cholecystokinin-pancreozymin in the pathogenesis of functional disorders of the hepatobiliary system]. Sheleketina II, Averianova LP, Leliukhina EV, Domashneva NA. Vrach Delo; 1980 Apr 03; (4):63-7. PubMed ID: 7385776 [No Abstract] [Full Text] [Related]
3. [Abnormal blood lipoproteins in hepatobiliary pathology]. Burstein M, Caroli J. Rev Med Chir Mal Foie; 1969 Apr 03; 44(3):125-38. PubMed ID: 5385890 [No Abstract] [Full Text] [Related]
4. [Fallacies in hepatobiliary therapy]. MARTINEZ LEON M. Prensa Med Mex; 1954 Jun 30; 19(6):143-6. PubMed ID: 13194561 [No Abstract] [Full Text] [Related]
5. [Diagnostic value of the Sellek-Frade reaction in hepatobiliary disease]. CELSI TH, TREVISAN AB. Prensa Med Argent; 1961 Jan 06; 48():19-24. PubMed ID: 13691892 [No Abstract] [Full Text] [Related]
6. [The physiopathology of hemorrhagic manifestations in hepatobiliary disease]. DIONIGI R. Riv Gastroenterol; 1960 Jan 06; 12():183-97. PubMed ID: 13723038 [No Abstract] [Full Text] [Related]
7. [Experimental study of the pathogenesis of dyskinesias of the hepatobiliary tract]. SARAGEA M, CZOPP H, MAIER H, STERESCU N, MORARIU D. Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1954 Jan 06; 6(3):519-65. PubMed ID: 14351855 [No Abstract] [Full Text] [Related]
8. [Role of Helicobacter species in hepatobiliary diseases]. Rasmussen ME, Lauritsen LE, Andersen LP. Ugeskr Laeger; 2008 Jun 02; 170(23):2010-5. PubMed ID: 18534163 [Abstract] [Full Text] [Related]
9. [The problem of anesthesia in patients with hepatobiliary diseases]. FOGLIATI E, AMASIO C. Minerva Anestesiol; 1959 Jun 02; 25(1-2):26-8. PubMed ID: 13656532 [No Abstract] [Full Text] [Related]
10. [Serum mucoproteins in hepatobiliary diseases]. BJORNESJO KB, EKMAN G. Nord Med; 1958 Sep 11; 60(37):1315-7. PubMed ID: 13590539 [No Abstract] [Full Text] [Related]
11. [Study of the concentration of blood ammonia in hepatobiliary diseases]. KATZ R, DUCCI H, VELASCO M, QUIROGA J. Rev Med Chil; 1959 Mar 11; 87(3):178-83. PubMed ID: 13658677 [No Abstract] [Full Text] [Related]
12. [Transaminases and seromucoid in hepatobiliary diseases: their integration in the biochemical pattern of these diseases]. SANCHEZ AGESTA A, MORA LARA RJ, DURAN CARA E, NUNEZ CARRIL J, RODRIGUEZ SANCHEZ FJ. Rev Clin Esp; 1961 Mar 15; 80():275-91. PubMed ID: 13746043 [No Abstract] [Full Text] [Related]
13. [Case of hepatobiliary ascariasis]. EREL SH, SASMAZ O. Turk Tip Cemiy Mecm; 1956 Nov 15; 22(11):598-601. PubMed ID: 13433826 [No Abstract] [Full Text] [Related]
14. The effect of hepatobiliary diseases on the serum acid precipitable globulin (APG) turbidity. GREENSPAN EM. J Mt Sinai Hosp N Y; 1955 Nov 15; 21(5):270-8. PubMed ID: 13233793 [No Abstract] [Full Text] [Related]
15. [Bone involvement in hepatobiliary diseases in infants & children]. ALAGILLE D. Bull Mem Soc Med Hop Paris; 1955 Nov 15; 74(28-29):717-22. PubMed ID: 13608280 [No Abstract] [Full Text] [Related]
16. Aquaporins in the hepatobiliary tract. Which, where and what they do in health and disease. Portincasa P, Palasciano G, Svelto M, Calamita G. Eur J Clin Invest; 2008 Jan 15; 38(1):1-10. PubMed ID: 18173545 [Abstract] [Full Text] [Related]
17. [Microflora of the upper part of the small intestine in diseases of the hepatobiliary system]. Knoke M, Bernhardt H. Ter Arkh; 1980 Jan 15; 52(2):71-2. PubMed ID: 7376102 [No Abstract] [Full Text] [Related]
19. [Transaminases. II. Significance of blood glutamic oxalacetic & glutamic pyruvic transaminases in hepatobiliary disorders]. ZERAH A, PEREZ C. Tunis Med; 1958 Dec 15; 36(10):611 passim. PubMed ID: 13635877 [No Abstract] [Full Text] [Related]
20. [Effect of the concomitant pathologies of the hepatobiliary system on the ulcer course and substantiation of the use of Essliver Forte as a part of the complex therapy]. Shkatova EIu, Mufazdalova IV, Khokhlacheva NA. Eksp Klin Gastroenterol; 2006 Dec 15; (4):43-7. PubMed ID: 17269423 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]